EZH2 and diffuse large B-cell lymphoma: To validate findings from our DCN and Deplink analysis, we independently performed a CRISPR genetic screen using a chromatin-focused gRNA library53 in a Cas9-expressing EZH2 mutant DLBCL cell line (KARPAS422) (Fig. 3a).